← FDA Drug Approvals (Drugs@FDA)

EPHEDRINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2024-07-18

Drug application

FDA Application #

ANDA219050

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPHEDRINE SULFATE

Generic name

EPHEDRINE SULFATE

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CAPLIN

Manufacturer

Caplin Steriles Limited

First approval

2024-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown